Monoclonal antibody combo keeps high-risk COVID-19 patients out of hospital
Treatment with two monoclonal antibodies lowers the odds of hospitalization for high-risk COVID-19 patients with mild to moderate illness, according to a new study.
from Latest News - UPI.com https://ift.tt/3t2o3kQ
via IFTTT
from Latest News - UPI.com https://ift.tt/3t2o3kQ
via IFTTT
Comments
Post a Comment